Yahoo Finance: Beacon Capital's Investments Validated by the Passing of the 'Right-To-Try' Bill

Beacon Capital, a venture and philanthropy arm of Beacon Pharmaceutical, is building a "Right-To-Try" platform. Right-To-Try legislation allows terminally ill patients access to investigational therapies – including medical devices, and biologics – that have passed basic safety and dosage testing (Phase I) with the FDA, but are not yet available to the broader public. READ ARTICLE


69 views0 comments